135 related articles for article (PubMed ID: 24912411)
1. Desensitization outcomes: quantifying and questioning.
Cole E; Tinckam KJ
Am J Transplant; 2014 Jul; 14(7):1475-6. PubMed ID: 24912411
[No Abstract] [Full Text] [Related]
2. Quantifying the risk of incompatible kidney transplantation: a multicenter study.
Orandi BJ; Garonzik-Wang JM; Massie AB; Zachary AA; Montgomery JR; Van Arendonk KJ; Stegall MD; Jordan SC; Oberholzer J; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Nelson PW; Wellen J; Bozorgzadeh A; Gaber AO; Montgomery RA; Segev DL
Am J Transplant; 2014 Jul; 14(7):1573-80. PubMed ID: 24913913
[TBL] [Abstract][Full Text] [Related]
3. Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants.
Pandey P; Setya D; Sinha VK; Devra AK; Bhatt AP; Pande A; Kumar P; Singh MK; Ranjan S
J Clin Apher; 2021 Jun; 36(3):299-312. PubMed ID: 33316838
[TBL] [Abstract][Full Text] [Related]
4. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
[TBL] [Abstract][Full Text] [Related]
6. Antibody-incompatible kidney transplantation in 2015 and beyond.
Higgins RM; Daga S; Mitchell DA
Nephrol Dial Transplant; 2015 Dec; 30(12):1972-8. PubMed ID: 25500804
[TBL] [Abstract][Full Text] [Related]
7. Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantation.
Del Bello A; Divard G; Belliere J; Congy-Jolivet N; Lanfranco L; Ricard R; Delas A; Colombat M; Esposito L; Hebral AL; Cointault O; Lefaucheur C; Loupy A; Kamar N
Clin Transplant; 2019 Oct; 33(10):e13681. PubMed ID: 31369170
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study.
Ko EJ; Yu JH; Yang CW; Chung BH;
Transpl Int; 2017 Dec; 30(12):1215-1225. PubMed ID: 28493630
[TBL] [Abstract][Full Text] [Related]
9. Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations.
Couzi L; Manook M; Perera R; Shaw O; Ahmed Z; Kessaris N; Dorling A; Mamode N
Transpl Int; 2015 Oct; 28(10):1205-15. PubMed ID: 26095452
[TBL] [Abstract][Full Text] [Related]
10. One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia.
Jalalonmuhali M; Ng KP; Mohd Shariff NH; Lee YW; Wong AH; Gan CC; Lim SK
Transplant Proc; 2020; 52(6):1718-1722. PubMed ID: 32448671
[TBL] [Abstract][Full Text] [Related]
11. Incompatible live-donor kidney transplantation in the United States: results of a national survey.
Garonzik Wang JM; Montgomery RA; Kucirka LM; Berger JC; Warren DS; Segev DL
Clin J Am Soc Nephrol; 2011 Aug; 6(8):2041-6. PubMed ID: 21784826
[TBL] [Abstract][Full Text] [Related]
12. The role of the altruistic unbalanced chain in exchange living donor renal transplantation: single-center experience.
Ahn BK; Kwon OJ; Kang CM
Transplant Proc; 2012 Jan; 44(1):17-21. PubMed ID: 22310567
[TBL] [Abstract][Full Text] [Related]
13. Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange.
Warren DS; Montgomery RA
Immunol Res; 2010 Jul; 47(1-3):257-64. PubMed ID: 20087679
[TBL] [Abstract][Full Text] [Related]
14. Kidney transplantation at Tokyo Women's Medical University.
Inui M; Ishida H; Omoto K; Tanabe T; Hattori M; Hirano H; Tanabe K
Clin Transpl; 2011; ():127-43. PubMed ID: 22755409
[TBL] [Abstract][Full Text] [Related]
15. Long-term Outcomes of ABO-Incompatible Living Donor Kidney Transplantation: A Comparative Analysis.
Shin E; Kwon SW; Yang WS; Baeck C; Yu H; Cho H; Park SK
Transplant Proc; 2015; 47(6):1720-6. PubMed ID: 26293040
[TBL] [Abstract][Full Text] [Related]
16. New choices for patients needing kidney transplantation across antibody barriers.
Higgins R; Hathaway M; Lowe D; Zehnder D; Krishnan N; Hamer R; Briggs D
J Ren Care; 2008 Jun; 34(2):85-93. PubMed ID: 18498573
[TBL] [Abstract][Full Text] [Related]
17. Transplanting the Untransplantable.
Holscher CM; Jackson KR; Segev DL
Am J Kidney Dis; 2020 Jan; 75(1):114-123. PubMed ID: 31255336
[TBL] [Abstract][Full Text] [Related]
18. Acceptable Donor-Specific Antibody Levels Before and After Desensitization Therapy in Living Donor Kidney Transplantation.
In JW; Nam M; Rho EY; Shin S; Hong YJ; Park KU; Song EY
Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013363
[TBL] [Abstract][Full Text] [Related]
19. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
20. Current Approaches to Desensitization in Solid Organ Transplantation.
Schinstock C; Tambur A; Stegall M
Front Immunol; 2021; 12():686271. PubMed ID: 34046044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
